Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Fo...

por Freriksen, Jolien J. M., van der Zanden, Tjitske M., Holsappel, Inge G. A., Molenbuur, Bouwe, de Wildt, Saskia N.
Publicado 2022

Does a Dose Calculator as an Add-On to a Web-Based Paediatric Formulary Reduce Calculation Errors in Paediatric Dosing? A Non-Randomized Controlled Study

por van der Zanden, Tjitske M., de Hoog, Matthijs, Windster, Jonathan D., van Rosmalen, Joost, van der Sijs, I. Heleen, de Wildt, Saskia N.
Publicado 2020

Diagnosis and Treatment of Chronic Neuropathic and Mixed Pain in Children and Adolescents: Results of a Survey Study amongst Practitioners

por de Leeuw, Thomas G., van der Zanden, Tjitske, Ravera, Simona, Felisi, Mariagrazia, Bonifazi, Donato, Tibboel, Dick, Ceci, Adriana, Kaguelidou, Florentia, de Wildt, Saskia N.
Publicado 2020

Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new...

por de Leeuw, Thomas G., Mangiarini, Laura, Lundin, Rebecca, Kaguelidou, Florentia, van der Zanden, Tjitske, Pasqua, Oscar Della, Tibboel, Dick, Ceci, Adriana, de Wildt, Saskia N.
Publicado 2019

Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and eff...

por de Leeuw, Thomas G., Mangiarini, Laura, Lundin, Rebecca, Kaguelidou, Florentia, van der Zanden, Tjitske, Della Pasqua, Oscar, Tibboel, Dick, Ceci, Adriana, de Wildt, Saskia N.
Publicado 2019

Chloroquine Dosing Recommendations for Pediatric COVID‐19 Supported by Modeling and Simulation

por Verscheijden, Laurens F. M., van der Zanden, Tjitske M., van Bussel, Lianne P. M., de Hoop‐Sommen, Marika, Russel, Frans G. M., Johnson, Trevor N., de Wildt, Saskia N.
Publicado 2020

A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of Concept

por Hartman, Stan J. F., Swaving, Joost G. E., van Beek, Stijn W., van Groen, Bianca D., de Hoop, Marika, van der Zanden, Tjitske M., ter Heine, Rob, de Wildt, Saskia N.
Publicado 2020

Benefit‐Risk Assessment of Off‐Label Drug Use in Children: The Bravo Framework

por van der Zanden, Tjitske M., Mooij, Miriam G., Vet, Nienke J., Neubert, Antje, Rascher, Wolfgang, Lagler, Florian B., Male, Christoph, Grytli, Helene, Halvorsen, Thomas, de Hoog, Matthijs, de Wildt, Saskia N.
Publicado 2021

Neonatal Drug Formularies—A Global Scope

por Shaniv, Dotan, Bolisetty, Srinivas, Young, Thomas E., Mangum, Barry, Ainsworth, Sean, Elbers, Linda, Schultz, Petra, Cucchi, Melanie, de Wildt, Saskia N., van der Zanden, Tjitske M., Caldwell, Neil, Smits, Anne, Allegaert, Karel
Publicado 2023

Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy

por van der Zanden, Tjitske M., Smeets, Nori J.L., de Hoop‐Sommen, Marika, Schwerzel, Michiel F.T., Huang, Hui Jun, Barten, Lieke J.C., van der Heijden, Joyce E.M., Freriksen, Jolien J.M., Horstink, Akira A.L., Holsappel, Inge H.G., Mooij, Miriam G., de Hoog, Matthijs, de Wildt, Saskia N.
Publicado 2022